Reckitt Benckiser Group (OTCMKTS:RBGLY) Hits New 1-Year Low at $10.24

Reckitt Benckiser Group plc (OTCMKTS:RBGLY - Get Free Report)'s share price hit a new 52-week low during trading on Wednesday . The stock traded as low as $10.24 and last traded at $10.29, with a volume of 1310476 shares. The stock had previously closed at $10.34.

Analyst Ratings Changes

Separately, BNP Paribas raised Reckitt Benckiser Group from an "underperform" rating to a "neutral" rating in a research note on Tuesday, January 9th. One analyst has rated the stock with a sell rating, four have issued a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, Reckitt Benckiser Group currently has an average rating of "Hold" and a consensus target price of $6,978.00.

Reckitt Benckiser Group Trading Down 0.5 %

The firm has a fifty day simple moving average of $12.47 and a two-hundred day simple moving average of $13.40.

Reckitt Benckiser Group Increases Dividend

The business also recently declared a dividend, which will be paid on Monday, June 3rd. Stockholders of record on Friday, April 12th will be issued a $0.2701 dividend. This is a positive change from Reckitt Benckiser Group's previous dividend of $0.18. The ex-dividend date of this dividend is Thursday, April 11th.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; vaginal care routine products; sore throat medications; and hair removal products under the Clearasil, Dettol, Durex, Gaviscon, Nurofen, Mucinex, Queen V, Strepsils, and Veet brands.